Position in PTCT
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$39,673,325
+$18,361,076 QoQ
Shares Held
582,318
+107.5% QoQ
Ownership
7.02%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ensign Peak Advisors, Inc holds $1,158,535,687 across 116 Biotechnology names. PTCT ranks #7 (3.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
215,165 | $96,079,779 | |
| 2 | INSM |
INSMED Inc
|
499,756 | $81,720,101 | |
| 3 | ABVX |
Abivax S.A.
|
631,838 | $70,355,161 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
836,552 | $62,122,351 | |
| 5 | ARGX |
Argenx SE
|
71,598 | $52,284,439 | |
| 6 | RPRX |
Royalty Pharma plc
|
932,650 | $44,739,220 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
This page
|
582,318 | $39,673,325 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
717,253 | $35,260,157 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $39,673,325 | 582,318 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $21,312,249 | 280,572 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $17,721,630 | 288,767 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,099,718 | 268,217 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $13,976,646 | 274,267 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $9,402,752 | 208,302 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,728,004 | 208,302 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,369,875 | 208,302 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $806,985 | 27,741 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $803,098 | 29,140 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $653,027 | 29,140 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,185,123 | 29,140 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,411,541 | 29,140 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,109,162 | 186,250 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $865,448 | 17,240 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $632,547 | 15,790 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $429,811 | 11,520 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $398,300 | 10,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $242,832 | 6,526 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $784,869 | 18,568 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $879,194 | 18,568 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $3,376,484 | 55,325 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,362,762 | 29,150 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $333,564 | 6,574 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $293,266 | 6,574 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||